PAR 4.35% 22.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3529

  1. 9,814 Posts.
    lightbulb Created with Sketch. 1249
    Thanks for sharing your thoughts as its always constructive to understand broader shareholder sentiment.

    However, your argument falls apart with "PR outsourcing most of the work". Yes he has made the very prudent decision to engage with proven consultants to structure negotiations in key regions, including China.

    This is one aspect of the role and at this juncture PAR needs someone that has the company's long term prospects at heart...rather than their own.

    PR whilst certainly not perfect is definitely focused on the end prize. And I suspect he is a quick learner on what the market now wants.

    BTW I've been made aware of some very successful and experienced investors recently joining the register. They like me like to invest during low vol and price action as it typically weeds out the impatient



    Last edited by Denial: 27/01/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
-0.010(4.35%)
Mkt cap ! $76.95M
Open High Low Value Volume
23.5¢ 23.5¢ 21.5¢ $258.8K 1.172M

Buyers (Bids)

No. Vol. Price($)
1 10139 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 6077 1
View Market Depth
Last trade - 16.10pm 13/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.